Verastem Inc (VSTM)

06:22 AM

Director Brian Stuglik (VSTM) awarded 36,000 Verastem RSUs with 2026–2027 vesting - Stock Titan

06:22 AM

06:21 AM

Verastem (NASDAQ: VSTM) awards 36,000 RSUs to director Rowinsky - Stock Titan

06:21 AM

06:19 AM

Verastem (VSTM) director Michelle Robertson awarded 36,000 RSUs - Stock Titan

06:19 AM

06:18 AM

Verastem (VSTM) director Anil Kapur receives 36,000 RSU equity award - Stock Titan

06:18 AM

06:12 AM

Verastem (VSTM) director awarded 36,000 RSUs vesting through 2027 - Stock Titan

06:12 AM

06:12 AM

Verastem (VSTM) director gets 36,000 RSU award vesting through 2027 - Stock Titan

06:12 AM

11:57 AM

Verastem Oncology Appoints Michael P. Bailey to Board of Directo - GuruFocus

11:57 AM

08:15 AM

Verastem (VSTM) stockholders back board slate, equity plans and auditor at 2026 meeting - Stock Titan

08:15 AM

07:49 AM

Verastem Oncology appoints Michael Bailey to board - Investing.com

07:49 AM

07:30 AM

Verastem Oncology Appoints Michael P. Bailey to its Board of Directors - Yahoo Finance

07:30 AM

May 22, 2026

VSTM Stock Chart | VERASTEM INC (NASDAQ:VSTM) - ChartMill

May 22, 2026

May 21, 2026

VSTM Stock Price, Quote & Chart | VERASTEM INC (NASDAQ:VSTM) - ChartMill

May 21, 2026

May 20, 2026

Verastem Q1 earnings call highlights - MSN

May 20, 2026

May 20, 2026

Verastem Inc at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus

May 20, 2026

May 18, 2026

Cancer Stocks That Are Advancing the Future of Oncology Care - TradingView

May 18, 2026

May 18, 2026

Verastem (VSTM) Loses 34.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

May 18, 2026

May 17, 2026

Verastem Q3 2025 Earnings Preview - MSN

May 17, 2026

May 15, 2026

Foresite (VSTM) holds 3,146,631 shares, reporting 3.6% stake - Stock Titan

May 15, 2026

May 15, 2026

Armistice Capital 5.23% stake in Verastem (VSTM) via managed fund - Stock Titan

May 15, 2026

May 15, 2026

RTW Funds, Roderick Wong Report 9.99% of Verastem (VSTM) - Stock Titan

May 15, 2026

May 15, 2026

Balyasny-affiliated holders report 1.36M shares in Verastem (VSTM) - Stock Titan

May 15, 2026

May 15, 2026

Verastem Oncology announces management changes - MSN

May 15, 2026

May 14, 2026

VSTM Maintained by Mizuho -- Price Target Lowered to $14.00 - GuruFocus

May 14, 2026

May 14, 2026

MSN Money - MSN

May 14, 2026

May 14, 2026

Mizuho Adjusts Price Target on Verastem to $14 From $16, Maintains Outperform Rating - Moomoo

May 14, 2026

May 13, 2026

Verastem, Inc. drives patient-focused efforts in rare ovarian cancer awareness - Traders Union

May 13, 2026

May 13, 2026

Mizuho Securities Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $14 - Moomoo

May 13, 2026

May 12, 2026

Press Release: Verastem Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Business Updates - Moomoo

May 12, 2026

May 12, 2026

Verastem Oncology to Present at Upcoming Investor Conferences - Barchart.com

May 12, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 11, 2026

Analysts Are Updating Their Verastem, Inc. (NASDAQ:VSTM) Estimates After Its First-Quarter Results - simplywall.st

May 11, 2026

May 11, 2026

Verastem, Inc. (NASDAQ:VSTM) Just Released Its First-Quarter Earnings: Here's What Analysts Think - Yahoo Finance

May 11, 2026

May 10, 2026

VSTM Slides As Verastem Inc. Selling Pressure Builds - timothysykes.com

May 10, 2026

May 09, 2026

BTIG Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $18 - Moomoo

May 09, 2026

May 09, 2026

Verastem Q1 Earnings Call Highlights - Barchart

May 09, 2026

May 09, 2026

Verastem (VSTM) Q4 Revenue Reaches US$17.5 Million Yet Heavy Losses Reinforce Bearish Views - Sahm

May 09, 2026

May 09, 2026

Verastem, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:VSTM) 2026-05-09 - Seeking Alpha

May 09, 2026

May 08, 2026

RBC Capital Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $15 - Moomoo

May 08, 2026

May 08, 2026

Verastem Inc Earnings Call Highlights Growth And Risk - TipRanks

May 08, 2026

May 08, 2026

Verastem (VSTM) Q1 2026 Earnings Transcript - AOL.com

May 08, 2026

May 08, 2026

VSTM Maintained by BTIG -- Price Target Lowered to $18.00 - GuruFocus

May 08, 2026

May 08, 2026

(VSTM) Movement as an Input in Quant Signal Sets - Stock Traders Daily

May 08, 2026

May 08, 2026

Q1 2026 Verastem Inc Earnings Call Transcript - GuruFocus

May 08, 2026

May 08, 2026

Verastem stock price target lowered to $18 by BTIG on revenue miss - Investing.com Canada

May 08, 2026

May 08, 2026

New rare ovarian cancer guide aims to ease diagnosis-to-care hurdles - Stock Titan

May 08, 2026

May 08, 2026

MA-VERASTEM-ONCOLOGY - Black Hills Pioneer

May 08, 2026

May 08, 2026

On World Ovarian Cancer Day, LGSOC Resource Guide Launches to Support People Living with Low-Grade Serous Ovarian Cancer - ChartMill

May 08, 2026

May 08, 2026

Verastem Q1 2026 Earnings Call Transcript - MarketBeat

May 08, 2026

May 08, 2026

Verastem: Q1 Earnings Snapshot - theheraldreview.com

May 08, 2026

May 08, 2026

Verastem, Inc. (VSTM) Stock Analysis: Exploring A Potential 189% Upside For Investors - DirectorsTalk Interviews

May 08, 2026

May 08, 2026

Verastem Oncology Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates - BioSpace

May 08, 2026

May 08, 2026

Verastem Inc (NASDAQ:VSTM) Mixed Q1 Results Disappoint on Revenue Miss - ChartMill

May 08, 2026

May 08, 2026

Verastem (VSTM) Reports $18.7 Million in Q1 2026 Revenue with Po - GuruFocus

May 08, 2026

May 07, 2026

Earnings call transcript: Verastem Q1 2026 shows strong revenue growth By Investing.com - Investing.com Australia

May 07, 2026

May 07, 2026

Earnings call transcript: Verastem Q1 2026 shows strong revenue growth - Investing.com

May 07, 2026